PCM
ALT icon

Perkins Capital Management’s Altimmune ALT Stock Holding History

Perkins Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-750
Closed -$10K – 133
2018
Q2 		$10K Sell
750
-345
-32% -$6.79K 0.01% 127
2018
Q1 		$38K Sell
1,095
-87
-7% -$4.36K 0.03% 115
2017
Q4 		$71K Sell
1,182
-478
-29% -$30.5K 0.07% 103
2017
Q3 		$116K Sell
1,660
-37
-2% -$2.75K 0.12% 90
2017
Q2 		$163K Sell
1,697
-36
-2% -$5.98K 0.18% 90
2017
Q1 		$422K Sell
1,733
-627
-27% -$335K 0.44% 74
2016
Q4 		$2.3M Sell
2,360
-373
-14% -$334K 2.52% 7
2016
Q3 		$2.38M Sell
2,733
-147
-5% -$115K 2.38% 7
2016
Q2 		$2.11M Sell
2,880
-299
-9% -$205K 2.42% 5
2016
Q1 		$1.8M Sell
3,179
-803
-20% -$411K 2.26% 8
2015
Q4 		$2.27M Sell
3,982
-70
-2% -$34.9K 2.44% 7
2015
Q3 		$1.62M Buy
4,052
+8
+0.2% +$3.79K 1.8% 14
2015
Q2 		$2.18M Sell
4,044
-252
-6% -$127K 1.92% 6
2015
Q1 		$2.1M Sell
4,296
-133
-3% -$66.3K 1.76% 13
2014
Q4 		$2.4M Sell
4,429
-477
-10% -$245K 2.06% 9
2014
Q3 		$2.62M Sell
4,906
-42
-0.8% -$22K 2.21% 5
2014
Q2 		$2.09M Buy
4,948
+175
+4% +$79.1K 1.47% 18
2014
Q1 		$2.62M Sell
4,773
-284
-6% -$166K 1.84% 10
2013
Q4 		$2.82M Sell
5,057
-118
-2% -$70.4K 1.9% 9
2013
Q3 		$3.26M Sell
5,175
-121
-2% -$69.3K 2.34% 5
2013
Q2 		$2.53M Buy
+5,296
New +$2.63M 2.01% 11

Other funds holding ALT

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Perkins Capital Management's ALT Position: Q3 2018 in Review

Perkins Capital Management sold out of Altimmune (ALT) in Q3 2018, closing a stake of 750 shares — an estimated $10K sold.

Perkins Capital Management first reported a position in ALT in Q2 2013 and held it in 21 quarters. The position peaked at $3.26M in Q3 2013. 16 funds tracked by Wall St. Rank hold ALT as of Q3 2018.

  • Perkins Capital Management reported no remaining Altimmune position as of Q3 2018 after selling out during the quarter.
  • Perkins Capital Management sold 750 Altimmune shares in Q3 2018, an estimated $10K.
  • Perkins Capital Management first reported a position in Altimmune in Q2 2013 and held it in 21 quarters.
  • Perkins Capital Management's Altimmune position peaked at $3.26M in Q3 2013.
  • 16 funds tracked by Wall St. Rank held Altimmune as of Q3 2018.

Based on Perkins Capital Management's 13F filing for Q3 2018, filed 22 Oct 2018.